Nantahala Capital Management »

Ocuphire Pharma shares owned by Nantahala Capital Management

Quarter-by-quarter ownership of Ocuphire Pharma (IRD) shares owned by Nantahala Capital Management from 13F filings

Historical chart of Nantahala Capital Management investment in Ocuphire Pharma

Tip: Access up to 7 years of quarterly data

All positions including Ocuphire Pharma held by Nantahala Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ocuphire Pharma by Nantahala Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $5.5M 3.3M 1.65
2025-06-30 $3.2M 3.3M 0.94
2025-03-31 $3.1M 3.2M 0.98

More positions owned by Nantahala Capital Management

Ishares Tr Russell 2000 Etf Put Option (IWM)
Edwards Lifesciences Put Option (EW)
Hilton Grand Vacations (HGV)
Establishment Labs Holdings Ord (ESTA)
Peloton Interactive Cl A Com (PTON)
Spdr Series Trust S&p Biotech Put Option (XBI)
Herbalife Com Shs (HLF)
Soleno Therapeutics (SLNO)
Ban (TBBK)
Uniqure Nv SHS (QURE)
Teva Pharmaceutical Inds Sponsored Ads Call Option (TEVA)
Viatris Call Option (VTRS)
Abivax Sa Sponsored Ads (ABVX)
Xtant Med Hldgs Com New (XTNT)
Fulcrum Therapeutics (FULC)

View all positions for Nantahala Capital Management

Top funds holding Ocuphire Pharma

Perceptive Advisors
BIOS Capital Management
Nantahala Capital Management
Vanguard Group
Mink Brook Asset Management
Opaleye Management
Adage Capital Partners GP
Bleichroeder
Voss Capital
Geode Capital Management
Renaissance Technologies
State Street Corporation
Creative Planning
Citadel Advisors
Two Sigma Investments

View all funds holding Ocuphire Pharma